MarketCapTrends
TRAW

Traws Pharma Inc. (TRAW)

NASDAQ · Healthcare

Traws Pharma Inc. annual/quarterly shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Traws Pharma Inc. shareholder equity for the quarter ending December 31, 2025 were -629,000, a 98.01% decrease year-over-year.
  • Traws Pharma Inc. shareholder equity for 2025 were -629,000, a 98.01% decrease from 2024.
  • Traws Pharma Inc. shareholder equity for 2024 were -31.6M, a 396.38% decrease from 2023.
  • Traws Pharma Inc. shareholder equity for 2023 were 10.7M, a 62.30% decrease from 2022.
  • Traws Pharma Inc. shareholder equity for 2022 were 28.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Traws Pharma Inc. Annual Shareholder Equity (Millions of US $)
2025$-1
2024$-32
2023$11
2022$28
2021$46
2020$6
2019$12
2018$5
2017$-12
2016$4
2015$10
2014$23
2013$80
2012$-158
Traws Pharma Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$-1
2024-12-31$-32
2023-12-31$11
2022-12-31$28
2021-12-31$46
2020-12-31$6
2019-12-31$12
2018-12-31$5
2017-12-31$-12
2016-12-31$4
2015-12-31$10
2014-12-31$23
2013-12-31$80
2012-12-31$-158

Traws Pharma Inc. Shareholder Equity — FAQ

Traws Pharma Inc. (TRAW) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TRAW's shareholder equity history?

The chart and table above show Traws Pharma Inc.'s shareholder equity by year and by quarter, including the growth rate.